Prognosis
J&J Says Putting Drug Prices in Ads May Scare Away Patients
- Administration plans to make drugmakers disclose prices in ads
- ‘They don’t want people seeing just how high those prices are’
This article is for subscribers only.
Johnson & Johnson, the world’s most valuable health-care company, says U.S. patients may avoid buying their medications if they see the prices in television ads.
A proposal from the Trump administration forcing drugmakers to disclose the list price of any medication that costs more than $35 could discourage some from seeking treatment, executives from Johnson & Johnson said on an earnings conference call Tuesday.